The NF2 gene: elucidation of tumor suppressor function
The NF2 gene: elucidation of tumor suppressor function
批准号:
6747904
负责人:
JOSEPH KISSIL
金额:
$2.29万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-05-01 至 2004-10-11
关键词:
biological signal transductioncell proliferationgenetic modelslaboratory mouseneoplasm /cancer geneticsnerve /myelin proteinneurofibromatosisphosphorylationpostdoctoral investigatorprotein isoformsprotein protein interactionprotein structure functionserine threonine protein kinasetumor suppressor proteins
中文摘要
描述(申请人提供):神经纤维瘤病2型(NF2)是一种遗传性疾病,其特征是发展为第八脑神经的雪旺细胞瘤。NF2基因编码一种与ERM蛋白moesin、ezrin和Radixin高度相关的蛋白质,因此被称为Merlin。ERM蛋白被认为是细胞膜-细胞骨架连接物。Merlin至少部分受RAC/Cdc42依赖的磷酸化调控。最近的数据表明,Merlin可能是RAC/CDC42信号通路的负调控因子。该项目的重点是研究Merlin的肿瘤抑制特性,以及通过Merlin将细胞外信号与细胞骨架组织和/或细胞增殖状态联系起来的信号通路。这项工作涉及两个结合的方法:1)了解Merlin可能如何与RAC/CDC42信号通路相互作用和调节。2)Merlin的结构/功能研究,包括将该蛋白的异构体和突变形式导入NF2缺陷细胞。具体地说,将检测影响Merlin磷酸化的突变。拟议的项目应该有助于阐明Merlin对生长的抑制作用,以及可能与RAC/CDC42途径的相互作用。这应该有助于更好地理解Merlin在正常细胞中的功能以及它在肿瘤发展过程中丢失的后果。这些信息将直接帮助寻找有效的治疗方法。
英文摘要
DESCRIPTION (provided by applicant): Neurofibromatosis type 2 (NF2) is an inherited disorder characterized by development of Schwann cell tumors of the eighth cranial nerve. The NF2 gene codes for a protein highly related to the ERM proteins moesin, ezrin and radixin and was thus termed merlin. The ERM proteins are thought to function as cell membrane-cytoskeleton linkers. Merlin is regulated, at least in part, by Rac/cdc42-dependent phosphorylation. Recent data implicates merlin as a possible negative regulator of the Rac/cdc42 signaling pathway. The proposed project focuses on the study of the tumor suppressive properties of merlin and the signaling pathways connecting extracellular signals to cytoskeletal organization and/or the proliferative state of the cell, via merlin. The work involves two combined approaches: 1) Understanding how merlin might interact with and regulate, the Rac/cdc42 signaling pathway. 2) Structure/function studies of merlin involving introduction of isoforms and mutated forms of the protein into Nf2-deficient cells. Specifically, mutations effecting merlin phosphorylation will be examined. The proposed project should shed light on the growth suppressive effects of merlin and possible cross-talk with the Rac/cdc42 pathway. This should lead to a better understanding of merlin function in normal cells and the consequences of its loss in tumor development. Such information will directly assist in the search for effective therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elucidating the epigenetic landscape of neurofibromatosis and development of therapeutic targets
-
批准号:10473771
-
项目类别:
-
资助金额:$42.32万
-
财政年份:2021
-
负责人:JOSEPH KISSIL
-
依托单位:
Employing functionalized fragment libraries to identify therapeutic agents for neurofibromatosis type 2
-
批准号:10401628
-
项目类别:
-
资助金额:$28.96万
-
财政年份:2021
-
负责人:JOSEPH KISSIL
-
依托单位:
Elucidating the epigenetic landscape of neurofibromatosis and development of therapeutic targets
-
批准号:10680527
-
项目类别:
-
资助金额:$41.14万
-
财政年份:2021
-
负责人:JOSEPH KISSIL
-
依托单位:
Elucidating the epigenetic landscape of neurofibromatosis and development of therapeutic targets
-
批准号:10211400
-
项目类别:
-
资助金额:$44.13万
-
财政年份:2021
-
负责人:JOSEPH KISSIL
-
依托单位:
Employing functionalized fragment libraries to identify therapeutic agents for neurofibromatosis type 2
-
批准号:10704416
-
项目类别:
-
资助金额:$41.57万
-
财政年份:2021
-
负责人:JOSEPH KISSIL
-
依托单位:
CARM1-mediated regulation of YAP1 as a therapeutic target in lung cancer
-
批准号:10391561
-
项目类别:
-
资助金额:$42.87万
-
财政年份:2020
-
负责人:JOSEPH KISSIL
-
依托单位:
CARM1-mediated regulation of YAP1 as a therapeutic target in lung cancer
-
批准号:10613467
-
项目类别:
-
资助金额:$42.87万
-
财政年份:2020
-
负责人:JOSEPH KISSIL
-
依托单位:
Elucidating the epigenetic landscape of neurofibromatosis and development of therapeutic targets
-
批准号:10201375
-
项目类别:
-
资助金额:$47.22万
-
财政年份:2020
-
负责人:JOSEPH KISSIL
-
依托单位:
ConProject-003
-
批准号:9981228
-
项目类别:
-
资助金额:$11.31万
-
财政年份:2019
-
负责人:JOSEPH KISSIL
-
依托单位:
ConProject-001
-
批准号:9981226
-
项目类别:
-
资助金额:$11.76万
-
财政年份:2019
-
负责人:JOSEPH KISSIL
-
依托单位:
ConProject-002
-
批准号:9981227
-
项目类别:
-
资助金额:$16.31万
-
财政年份:2019
-
负责人:JOSEPH KISSIL
-
依托单位:
Development and validation of a genetically engineered model of neurofibromatosis type 2 to facilitate discovery of neurotherapeutics
-
批准号:9375911
-
项目类别:
-
资助金额:$47.72万
-
财政年份:2017
-
负责人:JOSEPH KISSIL
-
依托单位:
Identification and development of inhibitors of the Hippo-Yap pathway
-
批准号:9036349
-
项目类别:
-
资助金额:$43.92万
-
财政年份:2015
-
负责人:JOSEPH KISSIL
-
依托单位:
Identification and development of inhibitors of the Hippo-Yap pathway
-
批准号:9231398
-
项目类别:
-
资助金额:$35.14万
-
财政年份:2015
-
负责人:JOSEPH KISSIL
-
依托单位:
Mechanisms of cell contact inhibition and their dysregulation in cancer.
-
批准号:8799888
-
项目类别:
-
资助金额:$4.97万
-
财政年份:2013
-
负责人:JOSEPH KISSIL
-
依托单位:
Mechanisms of cell contact inhibition and their dysregulation in cancer.
-
批准号:9206182
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2013
-
负责人:JOSEPH KISSIL
-
依托单位:
Mechanisms of cell contact inhibition and their dysregulation in cancer.
-
批准号:8976866
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2013
-
负责人:JOSEPH KISSIL
-
依托单位:
Mechanisms of cell contact inhibition and their dysregulation in cancer.
-
批准号:8504613
-
项目类别:
-
资助金额:$41.34万
-
财政年份:2013
-
负责人:JOSEPH KISSIL
-
依托单位:
Mechanisms of cell contact inhibition and their dysregulation in cancer.
-
批准号:8792418
-
项目类别:
-
资助金额:$41.34万
-
财政年份:2013
-
负责人:JOSEPH KISSIL
-
依托单位:
Mechanisms of cell contact inhibition and their dysregulation in cancer.
-
批准号:8609082
-
项目类别:
-
资助金额:$40.93万
-
财政年份:2013
-
负责人:JOSEPH KISSIL
-
依托单位:
海外基金